Medical Polyoxymethylene Market (2024 - 2030)

Medical Polyoxymethylene Market Summary

The global medical polyoxymethylene market size was estimated at USD 117.69 million in 2023 and is projected to reach USD 183.46 million by 2030, growing at a CAGR of 6.4% from 2024 to 2030. The growing need for sustainable materials in the healthcare industry, spurred by increased environmental awareness is expected to create demand for medical POM over the forecast period.

The significant features such as superior mechanical quality, biocompatibility, and resilience to chemicals and sterilization procedures has widely employed POM in a variety of medical applications.

The market is predicted to grow significantly in the coming years as demand for medical devices and equipment rises. It is extensively used in the manufacture of medical devices such as surgical instruments, catheters, implants, and drug delivery systems. Furthermore, the growing geriatric population and the rise in chronic diseases have led to increased demand for medical devices and equipment. Furthermore, technological advances, the expansion of the medical device sector, increasing urbanization, and economic growth are projected to boost the market throughout the forecast period.

One of the prominent trend in the market is the rising incidences of cardiovascular diseases (CVD) worldwide which are significantly driving the demand for medical polyoxymethylene (POM). As cardiovascular diseases are becoming increasingly prevalent, the requirement for advanced medical devices and components, such as catheters, stents, and valve replacements, is escalating globally.

Drivers, Opportunities & Restraints

The global medical polyoxymethylene market has witnessed significant growth in recent years. The aging population contributes to the market growth. The prevalence of cardiovascular diseases tends to increase due to advancing age and leading to a high demand for medical interventions and devices.

The market presents numerous prospects for growth and innovation, fueled by changing industry demands, technological advancements, and developing worldwide trends. The use of POM in creating biocompatible scaffolds and other components is likely to expand, presenting a significant growth opportunity for the market. The biocompatibility of POM is a critical factor in its suitability for tissue engineering applications.

The market is growing at a rapid rate, however, the market faces various challenges. Stringent regulations on the use of thermoplastics, combined with competition from traditional materials, are significant factors that could restrain the market growth.

Application Insights

Insulin pens dominated the product segment in the market with a 34.51% revenue share in 2023. The surge in demand for insulin pens as well as an increase in manufacturing are predicted to fuel the expansion of the engineering plastics industry, including POM. An insulin pen is used to inject insulin into diabetic individuals (most of whom have type 1 diabetes). Furthermore, the use of insulin pens is rising rapidly due to their ease of use and low cost.

Additionally, the use of insulin pens is increasing as the incidence of diabetes people increases. Due to its particular qualities to endure continuous use and other handling procedures, medical POM is often used in the manufacture of insulin pens. Furthermore, the ability of medical POM to retain its shape despite exposure to varying temperatures and pressures assures optimal pen operation and the prevention of damage or leakage to the insulin cartridge, resulting in its use in insulin pens.

Furthermore, the integration of properties possessed by such thermoplastics makes them beneficial for usage in a wide range of applications, including dry powder inhalers and metered dose inhalers (MDIs). The market is predicted to expand as demand for inhalers rises.

Type Insights

The copolymer segment dominated the market with more than 63.0% share of the global revenue in 2023. Accounting to its constructive and mechanical capabilities, which make it a suitable material to replace metal in the construction of a variety of medical devices. Owing to its processing properties, as well as thermal & dimensional stability, hardness, strength, ultra-high modulus, rigidity, dielectric strength, low friction coefficient & gas/vapor permeability, and enhanced retention it is expected to create demand for copolymer POM in the medical industry.

Homo-polymer POM possesses characteristics including high strength, durability, hardness, great impact & wear resistance making it suitable for medical applications. However, its combustion gases are very toxic making it harmful to the environment, and thus restraining the usage of homo-polymer POM.

In addition, several ongoing R&D activities to expand the medical application scope in the production of medical devices such as insulin pens, trays, inhalers, surgical instruments, and others are expected to boost the medical POM market. Efficient production and utilization of raw materials, easy customization of complex medical devices, and low weight are likely to augment the demand for polyoxymethylene in the global medical industry over the forecast period.

Regional Insights

North America is experiencing positive growth for POM in the medical industry, driven by the growth in medical device production, a high standard of living, and a growing aging population. Well-developed infrastructure along with the presence of renowned medical device manufacturers propelling the development of the medical industry in this region which in turn is creating the application scope of the market in this region.

U.S. Medical Polyoxymethylene Market Trends

The U.S. medical polyoxymethylene market dominated the North American market and is expected to grow at a significant rate from 2024 to 2030. The U.S. plays a major role in the market, with several factors contributing to its significance. The well-developed infrastructure and the presence of renowned medical device manufacturers propel the development of the medical industry in the U.S., creating significant application scope for the market in this country.

Europe Medical Polyoxymethylene Market Trends

The medical polyoxymethylene market in Europe is experiencing significant growth due to several key drivers. Europe is a major industrial hub with extensive manufacturing capacity. The region is prosperous and has high income levels, which results in high expenditure on healthcare. The rise in developments related to medical equipment and device technologies owing to the presence of numerous universities and centers engaged in research & development activities is expected to drive the market growth in the region.

Asia Pacific Medical Polyoxymethylene Market Trends

Asia Pacific medical polyoxymethylene market dominated the global market and accounted for a 45.49% share of the global revenue in 2023. The expansion of the medical sector in developing nations such as China, Japan, South Korea, and India provides lucrative potential for the growth of the Asia Pacific medical POM market. The presence of a strong industrial foundation, as well as the presence of key manufacturers, is primarily accountable for the growth of the medical POM market in this region. Furthermore, increased urbanization, as well as an increase in the incidence of chronic diseases, is boosting market expansion in the region. Another element boosting the industry in the region is the simple accessibility and availability of raw materials, combined with inexpensive labor and low production costs.

Key Medical Polyoxymethylene Company Insights

Key manufacturers operating in the market include Kolon ENP, BASF SE, Celanese Corporation, Polyplastics Co., Ltd., and ASAHI KASEI CORPORATION, among others. The market is categorized as a competitive landscape with several key players driving innovation and market growth. Major companies are investing heavily in research and development to enhance the performance, cost-effectiveness, and sustainability of their products.

Recent Developments

• In May 2024, Celanese Corporation announced the conversion of its POM-making process into a sustainable practice. The company aims to ensure that its production facility in Bishop, Texas in the U.S. achieves a net zero carbon footprint through these initiatives.

• In June 2023, BASF SE announced changes in its direct business for the Ultraform in Europe. As per these changes, the company announced the transfer of its POM sales process to its long-standing partners Ultrapolymers Group and ALBIS.

• In March 2023, Asahi Kasei Asaclean Americas (AKAC), a global supplier of purging compounds and concentrates, and Asahi Kasei Plastics North America (APNA), one of the global compounders of advanced engineered polymers announced their merger, effective from April 1, 2023. The resultant firm includes copolymer POM in its broad product portfolio.

Medical Polyoxymethylene Market